Primary amyloidosis with pulmonary involvement which presented exudative pleural effusion and high fever

Internal Medicine

Volumn 42, Issue 8, 2003, Pages 756-760

  Fujimoto, Naoki ^a   Masuoka, Hiroshi ^b   Kosaka, Hiroko ^c   Ota, Satoshi ^c   Ito, Masaaki ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Suzuka Kaisei Hospital   (Japan)

^c Matsusaka Central Hospital   (Japan)

Author keywords

Melphalan; Prednisolone; Primary amyloidosis; Refractory pleural effusion

Indexed keywords

AMYLOID; ANTIBIOTIC AGENT; MELPHALAN; PREDNISOLONE;

AGED; AMYLOIDOSIS; ARTICLE; BACTERIUM CULTURE; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; CYTOPATHOLOGY; DYSPNEA; FATIGUE; FEVER; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; LUNG EXTRAVASCULAR FLUID; LYMPHADENITIS; LYMPHATIC DRAINAGE; MALE; PLEURA EFFUSION; SURGICAL DRAINAGE; SYMPTOMATOLOGY; THORACOCENTESIS; THORAX RADIOGRAPHY; TRACHEAL BIOPSY;

EID: 0041472279     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.756     Document Type: Article

References (12)

1. Utz JP, Swenson SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic Experience from 1980 to 1993. Ann Intern Med 124: 407-413, 1996.
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32: 45-59, 1995.
3. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336: 1202-1207, 1997.
4. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100: 290-298, 1996.
5. Falk RH, Comenzo RL, Skinner M. The systemic amyloidosis. N Engl J Med 337: 898-909, 1997.
6. Gertz MA, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Kyle RA. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis. J Clin Oncol 17: 262-267, 1999.
7. Maeno T, Sando Y, Tsukagoshi M, et al. Pleural amyloidosis in a patient with intractable pleural effusion and multiple myeloma. Respiology 5: 79-80, 2000.
8. Ikeda S, Takabayashi Y, Maejima Y, et al. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis. Amyloid 6: 292-296, 1999.
9. Bontemps F, Tillie-Leblond I, Coppin MC, et al. Pleural amyloidosis: thoracoscopic aspects. Eur Respir J 8: 1025-1027, 1995.
10. Astoul P, Cheikh R, Cabanot C, Vialette JP, Vestri R, Boutin C. Pleural amyloidosis: thoracoscopic diagnosis and physiopathological approach. Amylose pleurale. Rev Mal Respir 9: 629-631, 1992 (in French).
11. Kanoh T, Suzuki K, Kawaguchi S. Multifocal nodular AL amyloidosis in primary Sjögren's syndrome. Rinsho Ketsueki 39: 1157-1162, 1998 (in Japanese, Abstract in English).
12. Olofsson BO. Pulmonary function in familial amyloidosis with polyneuropathy. Acta Med Scand 209: 379-384, 1981.